Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
hPTH-(1-34) and Alendronate in Postmenopausal Osteoporosis
NCT00000400Phase 2Completed
- Sponsor
- Massachusetts General Hospital
- Start
- Aug 1999
- Primary completion
- Apr 2006
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of teriparatide in osteoporosis, sponsored by Massachusetts General Hospital. Started Aug 1999; status: completed.
02
Drugs
teriparatide
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT00000400.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00000400.